News

a. Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ……….Issued in the interest of investors. b. KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. c. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. d. "Investment in Securities Market/Commodity Market is subject to Market Risk." e. Dear Investor if you wish to revoke your un-executed e-DIS mandate, please mail us with ISIN and quantity on dp@ganeshstock.com by same day EOD. f. RISK DISCLOSURES ON DERIVATIVES: i. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses. ii. On an average, loss makers registered net trading loss close to ₹ 50,000. iii. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. iv. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost. v. Source: https://www.sebi.gov.in/reports-and-statistics/research/jan-2023/study-analysis-of-profit-and-loss-of-individual-traders-dealing-in-equity-fando-segment_67525.html vi. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of individual Traders dealing in equity Futures and Options (F&O) Segment”. wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Corporate News

Genomic Valley Biotech Limited to review financial results at October 30 board meeting As On :21-Oct-26 13:41

Company

Useful Links